Last $0.06 USD
Change Today +0.001 / 1.69%
Volume 711.5K
KBLB On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

kraig biocraft laboratories (KBLB) Snapshot

Open
$0.06
Previous Close
$0.06
Day High
$0.06
Day Low
$0.06
52 Week High
05/7/13 - $0.11
52 Week Low
12/17/13 - $0.05
Market Cap
39.3M
Average Volume 10 Days
1.1M
EPS TTM
$-0.0005
Shares Outstanding
654.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KRAIG BIOCRAFT LABORATORIES (KBLB)

Related News

No related news articles were found.

kraig biocraft laboratories (KBLB) Related Businessweek News

No Related Businessweek News Found

kraig biocraft laboratories (KBLB) Details

Kraig Biocraft Laboratories, Inc., a development stage company, focuses on developing protein based fibers using recombinant DNA technology for commercial applications in specialty fiber and technical textile industries. Its products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; composite materials for the aero-space industry; and for ballistic protection by the defense industry. The company was founded in 2006 and is based in Lansing, Michigan.

kraig biocraft laboratories (KBLB) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $267.1K
Compensation as of Fiscal Year 2012.

kraig biocraft laboratories (KBLB) Key Developments

Kraig Biocraft Laboratories, Inc. announced delayed annual 10-K filing

On 04/01/2014, Kraig Biocraft Laboratories, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Kraig Biocraft Laboratories, Inc. Amends Articles of Incorporation

Effective December 17, 2013, Kraig Biocraft Laboratories, Inc. amended its Articles of Incorporation to designate Series A of the Company's preferred stock, no par value. Under the amendment, there are two shares of Series A preferred stock authorized. The holder of each share of the Series A preferred stock is entitled to vote together with the holders of the Company's common stock on all matters upon which the Company's stockholders may vote. Each share of Series A preferred stock is entitled to 200,000,000 votes on all such matters. Each share of Series A Preferred Stock is convertible into one share of the Company's common stock at the holder's option.

Kraig Biocraft Laboratories, Inc. Amends its Articles of Incorporation

Effective November 15, 2013, Kraig Biocraft Laboratories, Inc. amended its Articles of Incorporation to add: a new Article 9: Any public notice or notice to the shareholders, including notice of meetings of the shareholders and notices which are permitted or required by law to shareholders, may be made by publication on the company’s website, or by other electronic means, to the extent that such means of publication are allowed by applicable law. New Article 10: Any action permitted to be taken at a shareholders' meeting may be taken without a meeting, and without prior notice, if consents in writing setting forth the action so taken are signed by the holders of outstanding shares having not less than the minimum number of votes that would be required to authorize or take the action at a meeting at which all shares entitled to vote on the action were present and voted. New Article 11: The Board of Directors is expressly authorized at any time, and from time to time, to (x) classify any unissued shares in one or more classes or in one or more series within a class, (y) reclassify any unissued shares of any class into one (1) or more classes or into one (1) or more series within one (1) or more classes, or (z) reclassify any unissued shares of any series of any class into one (1) or more classes or into one (1) or more series within a class; with such voting powers and such designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions providing for the issue thereof adopted by the Board of Directors, and as are not stated and expressed in these Articles of Incorporation, or any amendment thereto.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBLB:US $0.06 USD +0.001

KBLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KBLB.
View Industry Companies
 

Industry Analysis

KBLB

Industry Average

Valuation KBLB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KRAIG BIOCRAFT LABORATORIES, please visit www.kraiglabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.